Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-04

Clinical Trial Update: MOnitoring REsynchronization deviCes and cARdiac patiEnts [NA]

View source ↗

Summary

This clinical trial update reports termination of NCT00885677 on monitoring resynchronization devices in heart failure patients, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cardiac Resynchronization Therapy device

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure | NA | Status: TERMINATED | Results posted: 2017-04-04